Retisert Bausch & Lomb - Treatment for Chronic Non-Infectious Uveitis
Retisert is an intravitreal implant containing a tiny reservoir of the anti-inflammatory corticosteroid fluocinolone acetonide, which is delivered for approximately two-and-a-half years directly to the back of the eye. Retisert is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.Posted: April 2005
Retisert (fluocinolone acetonide) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
